CRS
Carpenter Technology Corporation
CRS has slightly lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CRS overall, supported by stronger valuation and stronger fundamentals.
CRS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Healthy |
CRS's revenue, profitability, cash flow and balance sheet are all currently healthy.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $222 | -26% |
| Forward | 22x | $300 | — |
| Current | 26x | $300 | — |
| Fair | 38x | $427 | +43% |
| Expensive | 50x | $572 | +91% |
Historical ranges are pointers, not guarantees.
CRS's PE is in its cheap range at 26x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CRS in the historical PE scenario, which offers more potential upside but is not a forecast.
CRS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CRS, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.93 | +23% |
| Q3 2026 | $11.34 | +39% |
| Q2 2026 | $10.52 | +42% |
| Q1 2026 | $9.50 | +35% |
| Q4 2025 | $8.61 | +62% |
| Q3 2025 | $8.18 | +82% |
| Q2 2025 | $7.42 | +101% |
| Q1 2025 | $7.06 | +169% |
| Q4 2024 | $5.30 | +84% |
CRS's earnings per share have climbed steadily: $11.34 over the past year, up 39% from the year before, and higher year over year for 20 quarters in a row.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CRS on earnings, with stronger typical year-over-year growth.
CRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $798.2M | +8.8% |
| Q2 2026 | $851M | +13% |
| Q1 2026 | $811.5M | +12% |
| Q4 2025 | $728M | +7.5% |
| Q3 2025 | $733.7M | +2.2% |
| Q2 2025 | $755.6M | -5.4% |
| Q1 2025 | $727M | +6.1% |
| Q4 2024 | $676.9M | +8.4% |
CRS's revenue is recovering but still below its 2023 peak: $798M last quarter, up 8.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | +3.7 points |
| Q2 2026 | 24% | +4.3 points |
| Q1 2026 | 23% | +4 points |
| Q4 2025 | 21% | +3.8 points |
| Q3 2025 | 21% | +5.1 points |
| Q2 2025 | 20% | +6.5 points |
| Q1 2025 | 19% | +7.9 points |
| Q4 2024 | 18% | +6.4 points |
CRS has the edge over VRT on profitability, with a higher operating margin.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT's operating margin was 23% last quarter, up 3.5 points from the same quarter a year ago, near the top of its range since 2020.
CRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$24.9M | -$21.5M |
| Q2 2026 | $155M | -23% |
| Q1 2026 | $124.8M | +267% |
| Q4 2025 | $85.9M | +123% |
| Q3 2025 | -$3.4M | -126% |
| Q2 2025 | $200.1M | +41% |
| Q1 2025 | $34M | -45% |
| Q4 2024 | $38.6M | +$49.4M |
CRS usually generates cash, though not every quarter: the latest was −$25M, but it generated $341M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CRS on cash flow, with more consistent year-over-year improvement.
CRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -200K shares |
| 1 year | -0.8% | -400K shares |
| 3 years | +0.2% | +100K shares |
| 5 years | +3.1% | +1.5M shares |
| Available history | +3.1% | +1.5M shares |
CRS has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $133.9M |
| Q2 2026 | $45.2M |
| Q1 2026 | $52.7M |
| Q4 2025 | $32.1M |
| Q3 2025 | $49.1M |
| Q2 2025 | $24.1M |
| Q1 2025 | $37.5M |
| Q4 2024 | $8.2M |
CRS spent $264M buying back its own shares over the past year, up 122% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 1.0x | Very low |
CRS's net debt is less than a year of its operating earnings (EBITDA).
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CRS on leverage, with a lower net debt burden relative to earnings.
CRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.0 | Neutral |
| Stochastic | 4.9 | Oversold |
CRS's weekly RSI is 32 (neutral) and its Stochastic is 5 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CRS PE vs Industrials Sector
| Metric | CRS | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 9.9% above |
| PE % | 22 | 58 | 36 pts below |
CRS has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.7 | 11% below |
| 20 week MA | $448.1 | 33% below |
| 50 week MA | $420.4 | 29% below |
| 100 week MA | $326.6 | 8.3% below |
| 200 week MA | $206.4 | 45% above |
CRS has fallen below most of its moving averages, though it's still 45% above its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over CRS on trend strength, trading above more of its moving averages.
CRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.3 | $28.6 | -43% |
| 2021 | $28.6 | $29.0 | +1.2% |
| 2022 | $29.0 | $37.8 | +30% |
| 2023 | $37.8 | $70.8 | +87% |
| 2024 | $70.8 | $170.7 | +141% |
| 2025 | $170.7 | $334.4 | +96% |
| 2026 YTD | $334.4 | $299.6 | -10% |
CRS's yearly returns have swung widely, from +141% in 2024 to −43% in 2020. It's down 10% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CRS on returns for 2026, with the stronger performance.